Business
Why the Neuren (ASX:NEU) share price is moving higher today
Neuren Pharmaceuticals Ltd (ASX: NEU) shares are trending higher in early afternoon trade. This comes after the biotech company announced it has successfully completed manufacturing a drug substance for its Phase 2 trials.
At the time of writing, the Neuren share price has jumped to an intraday high of $1.28, up 1.99% for the day so far.
What did Neuren announce?
The Neuren share price is edging higher as investors appear pleased with the company’s progress.
According to its release, Neuren’s second drug candidate, NNZ-2591, has been manufactured ahead of Phase 2 trials. The company is currently preparing to submit Investigational New Drug…
-
General21 hours agoFour bodies found in central Queensland house fire
-
General10 hours agoCarrie Bickmore named Victorian Australian of the Year for work to progress brain cancer research
-
General22 hours agoSpud King expands business with $14 million South West orchard investment
-
General19 hours agoSydney man Danny Zayat found guilty of murdering Tatiana Dokhotaru in Liverpool apartment